Evidence map›Paper›PMID 37013904›Full record

ArticleBJPsych open2023

Antipsychotic treatment patterns in refugees and their Swedish-born peers with first-episode non-affective psychosis: findings from the REMAIN study.

Julia Spaton Goppers, Ellenor Mittendorfer-Rutz, Alexis E Cullen, Christopher Jamil de Montgomery, Antti Tanskanen, Marie Norredam, Heidi Taipale

Open access · goldAbstract read
In one paragraph

Article in BJPsych open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Julia Spaton GoppersDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden.
Ellenor Mittendorfer-RutzDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden.
Alexis E CullenDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden; and Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.ORCID https://orcid.org/0000-0002-3178-3920
Christopher Jamil de MontgomeryDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden; and Department of Public Health, Danish Research Centre for Migration, Ethnicity and Health (MESU), University of Copenhagen, Denmark.
Antti TanskanenDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden; and Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Finland.
Marie NorredamDepartment of Public Health, Danish Research Centre for Migration, Ethnicity and Health (MESU), University of Copenhagen, Denmark.
Heidi TaipaleDepartment of Clinical Neuroscience, Division of Insurance Medicine, Karolinska Institutet, Sweden; and Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Finland.ORCID https://orcid.org/0000-0002-3281-934X
Karolinska Institutet · SEUniversity of Copenhagen · DKUniversity of Eastern Finland · FIKing's College London · GB

Funding

Vetenskapsrådet 2018-05783
6 · The paper itself

Abstract

backgroundPrevious studies suggest that migrants tend to utilise antipsychotics less often than their native-born peers. However, studies examining antipsychotic use among refugees with psychosis are lacking.

aimsTo compare the prevalence of antipsychotic drug use during the first 5 years of illness among refugees and Swedish-born individuals with a newly diagnosed non-affective psychotic disorder, and to identify sociodemographic and clinical factors associated with antipsychotic use.

methodThe study population included refugees (

resultsRefugees were somewhat less likely to use antipsychotics at 1 year after first diagnosis compared with Swedish-born persons (37.1%

conclusionsOur findings suggest that refugees with non-affective psychotic disorders may need targeted interventions to ensure antipsychotic use during the early phase of illness.

Indexed as

antipsychoticsepidemiologyPsychotic disordersrefugeesschizophrenia

Identifiers

PMID37013904
PMCPMC10134221
OpenAlexW4362523981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.